ArticleHereditary cancer in clinical practice2021

Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences.

Mary E Velthuizen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.